RSS   Newsletter   Contact   Advertise with us
Post Online Media

Bicycle Therapeutics names chief scientific officer

Bicycle TherapeuticsBicycle Therapeutics, a biotechnology company, announced the appointment of Nicholas Keen as chief scientific officer.
Article continues below

READ MORE Bicycle Therapeutics names Stephen J. Hoffman as board chairman

Dr. Keen joins Bicycle from Novartis, where he served as the Cambridge (U.S.) head of oncology research. During his tenure at Novartis he was responsible for leading research from basic target identification and drug discovery through clinical trials.

Prior to his time at Novartis, Dr. Keen held positions of increasing responsibility in AstraZeneca’s UK oncology research group, ultimately leading the early lead generation group for oncology at AstraZeneca’s U.S. research site with a focus on epigenetic regulation.

Dr. Keen earned his B.A. in Natural Sciences, his Ph.D. in Virology and Cancer Biology at the University of Cambridge and completed his postdoctoral training in transcriptional biology at the MRC Laboratory of Molecular Biology in Cambridge.

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy